Currently viewing the tag: "Abbott"
finally a new comprehensive study on NGAL levels in Neonatals. The measurements and the study was conducted by Docteur Roszyk and Docteur Sapin at: Service de biochimie et biologie moléculaire, hôpital Estaing, CHU de Clermont-Ferrand, France – so as always there is reasons to cheer : Vive la France.. The interesting aspect of the study […]
NGAL measurement has a role to play in detecting AKI after Liver Transplantations. In a very interesting article found on Bioporto.com Taiwanese doctos have looked into that relationship.
Measurements in Taiwan are done using the NGALTest from BioPort (amongst others)
Concentrations of sCr and urinary creatinine (uCr) were measured using the Jaffe kinetic method […]
This week will see the verdict on the NGAL patent held by Phadia.
“Phadia – wasn’t that case solved years ago ?? “- you might ask… Well – lets just say that while the Legal system in Denmark might be just it is not exactly swift. The case – supposedly simple – has now dragged […]
In relation to the former post, stating that an evaluation of the The NGAL Test on BC 5822, had been carried out, the full text of the complete evaluation is now avaliable. Its showtime Folks, its: The NGAL Test versus the Rest: In short – the conclusion is – that the NGAL Test is immensely […]
Abbott takes on one of the many challenges Doctors face when dealing with AKI, new medicine helps prevent AKI stemming from cardiac surgery
http://www.renalbusiness.com/news/2012/05/abbott-pays-cash-for-aki-drug.aspx” rel=”nofollow”
Quote:
“ABBOTT PARK, Ill.—Still wheeling and dealing on the road up to its spinoff this year, the drug arm of Abbott Laboratories has snagged Action Pharma’s Phase IIb […]
Uncertainty about consequences of the recent decision by the European Patent Organisation’s (EPO) Opposition Division (OD) on the NGAL patent Is the ruling really vital for BioPorto … and in case it is not – why is it not so ? While we are still (after 8 weeks) sitting waiting for the EPO – OD’s […]
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard
